Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Bartłomiej Milanowski"'
Autor:
Piotr Kulinowski, Piotr Malczewski, Marta Łaszcz, Ewelina Baran, Bartłomiej Milanowski, Mateusz Kuprianowicz, Przemysław Dorożyński
Publikováno v:
Materials, Vol 15, Iss 6, p 2142 (2022)
3D printing by selective laser sintering (SLS) of high-dose drug delivery systems using pure brittle crystalline active pharmaceutical ingredients (API) is possible but impractical. Currently used pharmaceutical grade excipients, including polymers,
Externí odkaz:
https://doaj.org/article/7ae66a8489b74a8e89ed6fe8aa265a87
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 22, p 12406 (2021)
Nanosizing is an approach to improve the dissolution rate of poorly soluble drugs. The first aim of this work was to develop nanosuspension of cilostazol with liquid antisolvent precipitation (LASP) and its combination with ultrasound. Second, to sys
Externí odkaz:
https://doaj.org/article/68d9a4dff8194ab39b4c8d8602a6e447
Autor:
Katarzyna Barbara Wróblewska, Bartłomiej Milanowski, Małgorzata Kucińska, Szymon Plewa, Jolanta Długaszewska, Izabela Muszalska-Kolos
Publikováno v:
Pharmaceuticals, Vol 14, Iss 9, p 849 (2021)
This work investigated the potential of a novel formulation of eye drops containing a non-steroidal anti-inflammatory drug—choline salicylate (CS)—and hyaluronic acid (HA). Thus, these drops may exert both anti-inflammatory and regenerative activ
Externí odkaz:
https://doaj.org/article/e9bd237fa0784fa68166f8a00f460cca
Autor:
Bartłomiej Milanowski, Hanna Wosicka-Frąckowiak, Eliza Główka, Małgorzata Sosnowska, Stanisław Woźny, Filip Stachowiak, Angelika Suchenek, Dariusz Wilkowski
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1305 (2021)
Pharmaceutical products containing non-steroidal anti-inflammatory drugs (NSAIDs) are among the most prescribed topical formulations used for analgesic and antirheumatic properties. These drugs must overcome the skin barrier to cause a therapeutic ef
Externí odkaz:
https://doaj.org/article/2805abbc2d7644e8952c6038ca39a409
Autor:
Marcin Skotnicki, Barbara Jadach, Agnieszka Skotnicka, Bartłomiej Milanowski, Lidia Tajber, Marek Pyda, Jacek Kujawski
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 118 (2021)
The aim of this study was to characterize a 1:1 molar ratio of a pharmacologically relevant co-amorphous atorvastatin-irbesartan (ATR-IRB) system obtained by quench cooling of the crystalline ATR/IRB physical mixture for potential use in the fixed-do
Externí odkaz:
https://doaj.org/article/ce3390e283644d56b9a71e9975a3e90d
Autor:
Kinga Hyla, K. Koperwas, Krzysztof Chmiel, Rafał Łunio, Karolina Jurkiewicz, Daniel Żakowiecki, Marian Paluch, Aldona Minecka, Ewa Kamińska, Bartłomiej Milanowski, Barbara Hachuła, Kamil Kaminski
Publikováno v:
Molecular Pharmaceutics
In this paper, several experimental techniques [X-ray diffraction, differential scanning calorimetry (DSC), thermogravimetry, Fourier transform infrared spectroscopy, and broad-band dielectric spectroscopy] have been applied to characterize the struc
Publikováno v:
Journal of Drug Delivery Science and Technology. 74:103528
Autor:
Janina Lulek, Krystyna Prochaska, Monika Rojewska, Bartłomiej Milanowski, Aleksandra Bartkowiak
Publikováno v:
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 566:11-20
In this paper, we present results on the sorption and wettability of tablets containing mucoadhesive (Carbopol 974P NF, HEC) and film-forming (Kollidon VA 64) polymers, with fluconazole as a model active pharmaceutical ingredient (API), important fro
Autor:
Bartosz F. Grześkowiak, Marek Rychter, Janina Lulek, Mateusz Kempiński, Bartłomiej Milanowski, Anna Baranowska-Korczyc, Sławomir Borysiak, Emerson Coy, Marcin Jarek
Publikováno v:
Journal of Colloid and Interface Science. 536:310-327
Currently marketed drug-eluting stents are non-selective in their anti-restenotic action. New active substance introduction to polymeric stents and vascular grafts can promote early re-endothelialization, crucial in preventing implant restenosis. Add
Autor:
Piotr Rogowski, Bartłomiej Milanowski, Janina Lulek, Krzysztof Wentowski, Marek A. Bawiec, Ewa Puk, Dorota Danielak, Łukasz Konwicki, Grzegorz Garbacz, Michał Kątny, Jarosław Pieczuro, Maria Nogowska
Publikováno v:
AAPS PharmSciTech
Development of generic extended-release (ER) formulations is challenging. Especially under fed conditions, the risk of failure in bioequivalence trials is high because of long gastric residence times and susceptibility to food effects. We describe th